2014 has been a rough year for advocates of sepsis protocols. First, the long-awaited ProCESS trial did not show any benefit from use of the original early goal-directed therapy (EGDT) protocol used in the single-center 2001 trial by Rivers et al that, despite criticism, became the standard of care for the following decade. Patients cared for in the 2 non-EGDT arms [... read more]
The post Life after sepsis protocols: What now? (You decide.) appeared first on PulmCCM.
Olodaterol People with severe chronic obstructive pulmonary disease (COPD) often have persistent dyspnea or exacerbations despite the use of a single controller inhaler. (Controller inhalers for COPD most often include combination inhaled corticosteroid/long-acting beta agonists like Advair, Dulera and Symbicort [ICS/LABAs] and the long-acting anticholinergic agent Spiriva/tiotropium). These patients often take both a combination ICS/LABA and Spiriva, so-called [... read more]
The post Safe to stop inhaled steroids in COPD (and start more expensive drugs)? appeared first on PulmCCM.
The U.S. FDA approved the first two drugs proven to slow progression of idiopathic pulmonary fibrosis (IPF): pirfenidone (Esbriet by Roche, which bought Intermune) and nintedanib (Ofev by Boehringer Ingelheim) on Wednesday October 15. Both drugs will offer new hope for patients, and new pain to the insurance companies and the government who pay for them. Pirfenidone [... read more]
The post FDA approves pirfenidone (Esbriet) and nintedanib (Ofev) for IPF appeared first on PulmCCM.
Stroke Volume Variation and the Concept of Dose-Response Jon-Emile S. Kenny M.D. Awareness of the undulating pattern of an arterial line tracing is high amongst health professionals in the intensive care unit; certainly this is an aftereffect of a cacophony of studies and reviews pertaining to pulse pressure variation and fluid responsiveness in the operating [... read more]
The post ICU Physiology in 1,000 Words: Stroke Volume Variation and the Concept of Dose-Response appeared first on PulmCCM.
Feeding patients enterally (nasogastric or nasojejunal tube feedings) has been the standard of care for critically ill patients, based on weak evidence that it reduces infection rates; hence the adage “feed the gut, if you can.” That last caveat is included because so many critically ill patients have gastric motility impairment (with inability to achieve [... read more]
The post Total parenteral nutrition vs enteral nutrition: no difference in critically ill? (CALORIES trial) appeared first on PulmCCM.
Blood transfusions have been a central component of protocols for care of severe sepsis and septic shock, ever since the single-center 2001 Rivers trial included them in its interventions. Any benefit (or harm) caused by red cell transfusion independently was unknowable, and the therapy remained a core element of the so-called sepsis bundle. The Surviving Sepsis [... read more]
The post Transfusion for hemoglobin above 7 g/dL: no benefit in septic shock (TRISS Trial) appeared first on PulmCCM.